• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白的双分子荧光互补实验证明其在小鼠中与多巴胺能表型的寡聚化。

Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice.

机构信息

Shanghai Huashan Hospital, Fudan University, Shanghai, China; MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.

MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.

出版信息

EBioMedicine. 2018 Mar;29:13-22. doi: 10.1016/j.ebiom.2018.01.035. Epub 2018 Jan 31.

DOI:10.1016/j.ebiom.2018.01.035
PMID:29433982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5925445/
Abstract

Alpha-synuclein (αSyn) is encoded by the first causal gene identified in Parkinson's disease (PD) and is the main component of Lewy bodies, a pathological hallmark of PD. aSyn-based animal models have contributed to our understanding of PD pathophysiology and to the development of therapeutics. Overexpression of human wildtype αSyn by viral vectors in rodents recapitulates the loss of dopaminergic neurons from the substantia nigra, another defining pathological feature of the disease. The development of a rat model exhibiting bimolecular fluorescence complementation (BiFC) of αSyn by recombinant adeno-associated virus facilitates detection of the toxic αSyn oligomers species. We report here neurochemical, neuropathological and behavioral characterization of BiFC of αSyn in mice. Overexpression and oligomerization of αSyn through BiFC is detected by conjugated fluorescence. Reduced striatal dopamine and loss of nigral dopaminergic neurons are accompanied neuroinflammation and abnormal motor activities. Our mouse model may provide a valuable tool to study the role of αSyn in PD and to explore therapeutic approaches.

摘要

α-突触核蛋白(αSyn)是帕金森病(PD)中首个被确定的致病基因所编码,也是路易体的主要成分,路易体是 PD 的一种病理标志。基于 αSyn 的动物模型有助于我们理解 PD 的病理生理学,并为治疗方法的发展做出贡献。通过病毒载体在啮齿动物中过表达人类野生型 αSyn,可重现黑质多巴胺能神经元的丧失,这是该疾病的另一个明确的病理特征。通过重组腺相关病毒实现 αSyn 双分子荧光互补(BiFC)的大鼠模型的发展,有助于检测到有毒的 αSyn 寡聚物。我们在此报告 BiFC 的 αSyn 在小鼠中的神经化学、神经病理学和行为特征。通过共轭荧光检测到 BiFC 中 αSyn 的过表达和寡聚化。纹状体多巴胺减少和黑质多巴胺能神经元丧失伴随着神经炎症和异常运动活动。我们的小鼠模型可能为研究 αSyn 在 PD 中的作用和探索治疗方法提供了有价值的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d488/5925445/bb6179835577/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d488/5925445/2f22c8e9a682/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d488/5925445/5f73f1bf96ec/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d488/5925445/45da540b1c3f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d488/5925445/eea135e8e8cb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d488/5925445/6a997ad1d239/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d488/5925445/bb6179835577/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d488/5925445/2f22c8e9a682/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d488/5925445/5f73f1bf96ec/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d488/5925445/45da540b1c3f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d488/5925445/eea135e8e8cb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d488/5925445/6a997ad1d239/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d488/5925445/bb6179835577/gr6.jpg

相似文献

1
Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice.α-突触核蛋白的双分子荧光互补实验证明其在小鼠中与多巴胺能表型的寡聚化。
EBioMedicine. 2018 Mar;29:13-22. doi: 10.1016/j.ebiom.2018.01.035. Epub 2018 Jan 31.
2
Evaluation of the Effect of β-Wrapin AS69 in a Mouse Model Based on Alpha-Synuclein Overexpression.基于α-突触核蛋白过表达的小鼠模型中评估β-Wrapin AS69 的效果。
Biomolecules. 2024 Jun 25;14(7):756. doi: 10.3390/biom14070756.
3
rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.rAAV2/7 载体介导的小鼠黑质中 alpha-突触核蛋白的过表达诱导蛋白聚集和进行性剂量依赖性神经退行性变。
Mol Neurodegener. 2013 Nov 25;8:44. doi: 10.1186/1750-1326-8-44.
4
Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.α-突触核蛋白致密聚集体的耗散与一种新的帕金森病模型中多巴胺能神经元功能障碍和死亡的挽救有关。
Acta Neuropathol. 2019 Oct;138(4):575-595. doi: 10.1007/s00401-019-02023-x. Epub 2019 May 31.
5
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.AAV1/2 诱导的 A53T-α-突触核蛋白在黑质中的过表达导致具有路易小体样病理学和运动障碍的黑质纹状体系统变性:帕金森病的新小鼠模型。
Acta Neuropathol Commun. 2017 Feb 1;5(1):11. doi: 10.1186/s40478-017-0416-x.
6
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.MHC 类 II 转录激活因子调节帕金森病体内大鼠模型中种子化的α-突触核蛋白病理和多巴胺能神经退行性变。
Brain Behav Immun. 2021 Jan;91:369-382. doi: 10.1016/j.bbi.2020.10.017. Epub 2020 Oct 22.
7
Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein.AAV-Alpha 突触核蛋白 NAC 抗体给药改善过表达 Alpha 突触核蛋白的大鼠的运动行为。
Genes (Basel). 2021 Jun 21;12(6):948. doi: 10.3390/genes12060948.
8
14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.14-3-3 减轻体内预形成纤维模型中α-突触核蛋白的聚集和毒性。
Acta Neuropathol Commun. 2021 Jan 7;9(1):13. doi: 10.1186/s40478-020-01110-5.
9
Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.通过向黑质内注射预先形成的人源α-突触核蛋白寡聚体来模拟帕金森病神经病理学和症状。
Int J Mol Sci. 2020 Nov 12;21(22):8535. doi: 10.3390/ijms21228535.
10
Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain.新生鼠脑内 AAV 传递α-突触核蛋白可诱导成年鼠脑内发生病变。
Acta Neuropathol Commun. 2017 Jun 23;5(1):51. doi: 10.1186/s40478-017-0455-3.

引用本文的文献

1
Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson's Disease.外周 MC1R 激活调节免疫反应并在帕金森病小鼠模型中具有神经保护作用。
J Neuroimmune Pharmacol. 2023 Dec;18(4):704-717. doi: 10.1007/s11481-023-10094-7. Epub 2023 Dec 19.
2
Chemical and Biological Strategies for Profiling Protein-Protein Interactions in Living Cells.在活细胞中蛋白质-蛋白质相互作用的化学和生物学研究策略。
Chem Asian J. 2023 Jul 17;18(14):e202300226. doi: 10.1002/asia.202300226. Epub 2023 May 5.
3
The Role of Alpha-Synuclein Deposits in Parkinson's Disease: A Focus on the Human Retina.

本文引用的文献

1
Alpha-synuclein oligomers: a new hope.α-突触核蛋白寡聚物:新的希望。
Acta Neuropathol. 2017 Dec;134(6):819-838. doi: 10.1007/s00401-017-1755-1. Epub 2017 Aug 12.
2
Animal models of α-synucleinopathy for Parkinson disease drug development.用于帕金森病药物开发的α-突触核蛋白病动物模型。
Nat Rev Neurosci. 2017 Sep;18(9):515-529. doi: 10.1038/nrn.2017.75. Epub 2017 Jul 13.
3
Zeroing in on neurodegenerative α-synuclein.聚焦于神经退行性α-突触核蛋白。
α-突触核蛋白沉积在帕金森病中的作用:关注人类视网膜。
Int J Mol Sci. 2023 Feb 23;24(5):4391. doi: 10.3390/ijms24054391.
4
Monitoring α-synuclein aggregation.监测 α-突触核蛋白聚集。
Neurobiol Dis. 2023 Jan;176:105966. doi: 10.1016/j.nbd.2022.105966. Epub 2022 Dec 15.
5
Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson's disease.黑皮质素 1 受体激活可预防帕金森病模型中α-突触核蛋白病理。
Mol Neurodegener. 2022 Feb 23;17(1):16. doi: 10.1186/s13024-022-00520-4.
6
Monitoring the interactions between alpha-synuclein and Tau in vitro and in vivo using bimolecular fluorescence complementation.利用双分子荧光互补技术在体外和体内监测α-突触核蛋白与 Tau 之间的相互作用。
Sci Rep. 2022 Feb 22;12(1):2987. doi: 10.1038/s41598-022-06846-9.
7
Trophoblast glycoprotein is a new candidate gene for Parkinson's disease.滋养层糖蛋白是帕金森病的一个新候选基因。
NPJ Parkinsons Dis. 2021 Dec 7;7(1):110. doi: 10.1038/s41531-021-00252-0.
8
CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation.CK1BP 可减少α-突触核蛋白寡聚化和聚集,而不依赖于丝氨酸 129 磷酸化。
Cells. 2021 Oct 21;10(11):2830. doi: 10.3390/cells10112830.
9
LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons.LGALS3(半乳糖凝集素3)通过人类中脑多巴胺神经元的自噬溶酶体途径,介导对溶酶体膜损伤的非常规分泌的SNCA/α-突触核蛋白。
Autophagy. 2022 May;18(5):1020-1048. doi: 10.1080/15548627.2021.1967615. Epub 2021 Oct 6.
10
The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissues associated with glaucoma pathogenesis.RNA 结合蛋白和应激颗粒成分 ATAXIN-2 在与青光眼发病机制相关的小鼠和人组织中表达。
J Comp Neurol. 2022 Feb;530(2):537-552. doi: 10.1002/cne.25228. Epub 2021 Aug 18.
Nat Rev Drug Discov. 2017 May 31;16(6):371-373. doi: 10.1038/nrd.2017.95.
4
Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.病毒介导的少突胶质细胞α-突触核蛋白表达可模拟多系统萎缩。
Mov Disord. 2017 Aug;32(8):1230-1239. doi: 10.1002/mds.27041. Epub 2017 May 29.
5
AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models.腺相关病毒载体介导的基因传递至黑质多巴胺能神经元:对基因治疗和疾病模型的意义。
Genes (Basel). 2017 Feb 8;8(2):63. doi: 10.3390/genes8020063.
6
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.AAV1/2 诱导的 A53T-α-突触核蛋白在黑质中的过表达导致具有路易小体样病理学和运动障碍的黑质纹状体系统变性:帕金森病的新小鼠模型。
Acta Neuropathol Commun. 2017 Feb 1;5(1):11. doi: 10.1186/s40478-017-0416-x.
7
The melanoma-linked "redhead" MC1R influences dopaminergic neuron survival.与黑色素瘤相关的“红发基因”MC1R影响多巴胺能神经元的存活。
Ann Neurol. 2017 Mar;81(3):395-406. doi: 10.1002/ana.24852. Epub 2017 Jan 23.
8
The genetic background of Parkinson's disease: current progress and future prospects.帕金森病的遗传背景:当前进展与未来展望。
Acta Neurol Scand. 2016 Nov;134(5):314-326. doi: 10.1111/ane.12563. Epub 2016 Feb 12.
9
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.α-突触核蛋白纤维在局部和全身给药后会引起不同的突触核蛋白病。
Nature. 2015 Jun 18;522(7556):340-4. doi: 10.1038/nature14547. Epub 2015 Jun 10.
10
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations.靶向α-突触核蛋白治疗帕金森病:机制与治疗考量
Lancet Neurol. 2015 Aug;14(8):855-866. doi: 10.1016/S1474-4422(15)00006-X. Epub 2015 Jun 3.